Literature DB >> 32030673

Gastric Tumor Microenvironment.

Armando Rojas1, Paulina Araya2, Ileana Gonzalez2, Erik Morales2.   

Abstract

A compelling body of evidence has demonstrated that gastric cancer has a very particular tumor microenvironment, a signature very suitable to promote tumor progression and metastasis. Recent investigations have provided new insights into the multiple molecular mechanisms, defined by genetic and epigenetic mechanisms, supporting a very active cross talk between the components of the tumor microenvironment and thus defining the fate of tumor progression. In this review, we intend to highlight the role of very active contributors at gastric cancer TME, particularly cancer-associated fibroblasts, bone marrow-derived cells, tumor-associated macrophages, and tumor-infiltrating neutrophils, all of them surrounded by an overtime changing extracellular matrix. In addition, the very active cross talk between the components of the tumor microenvironment, defined by genetic and epigenetic mechanisms, thus defining the fate of tumor progression, is also reviewed.

Entities:  

Keywords:  Cancer-associated fibroblasts; Chronic inflammation; Exosomes; Extracellular matrix; Gastric cancer; Helicobacter pylori; MicroRNAs; Tumor microenvironment; Tumor-associated macrophages; Tumor-associated mast cells; Tumor-infiltrating neutrophils

Mesh:

Year:  2020        PMID: 32030673     DOI: 10.1007/978-3-030-36214-0_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  24 in total

1.  Bioinformatics analysis identifying FBXO45 gene as a potential oncogene in esophageal cancer.

Authors:  Jian Zhang; Yiping Zhou; Bo Zhang; Chunguo Wang; Baofu Chen; Haitao Ma
Journal:  J Gastrointest Oncol       Date:  2021-12

Review 2.  Applications and Achievements of Single-Cell Sequencing in Gastrointestinal Cancer.

Authors:  Zhenliang Xie; Jincheng Li; Pu Huang; Ye Zhang; Jingkuan Yang; Kangdong Liu; Yanan Jiang
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

Review 3.  The immune microenvironment in gastric adenocarcinoma.

Authors:  Yana Zavros; Juanita L Merchant
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-14       Impact factor: 73.082

Review 4.  Biomarkers for Precision Treatment in Gastric Cancer.

Authors:  Angelica Petrillo; Elizabeth C Smyth
Journal:  Visc Med       Date:  2020-09-25

5.  CFP is a prognostic biomarker and correlated with immune infiltrates in Gastric Cancer and Lung Cancer.

Authors:  Guoliang Cui; Le Geng; Li Zhu; Zhenyan Lin; Xuan Liu; Zhengyue Miao; Jintao Jiang; Xiaoke Feng; Fei Wei
Journal:  J Cancer       Date:  2021-04-12       Impact factor: 4.207

6.  MUC4 is a novel mediator in H. pylori infection-related pancreatic cancer.

Authors:  Yu Gong; Shuai Chen; Yue Fu; Yu Liu; Yipeng Wang; Haojun Yang; Hanyang Liu; Liming Tang
Journal:  Oncol Lett       Date:  2020-12-17       Impact factor: 2.967

7.  Immune Cell Landscape in Gastric Cancer.

Authors:  Yang Yang; Wei He; Zi-Rui Wang; Yu-Jiao Wang; Lan-Lan Li; Jian-Zhong Lu; Yan Tao; Jing Zhang; Sheng-Jun Fu; Zhi-Ping Wang; Shan-Hui Liu
Journal:  Biomed Res Int       Date:  2021-01-09       Impact factor: 3.411

Review 8.  Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications.

Authors:  Karim Rihawi; Angela Dalia Ricci; Alessandro Rizzo; Stefano Brocchi; Giovanni Marasco; Luigi Vincenzo Pastore; Fabiola Lorena Rojas Llimpe; Rita Golfieri; Matteo Renzulli
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

Review 9.  Diabetes mellitus contribution to the remodeling of the tumor microenvironment in gastric cancer.

Authors:  Armando Rojas; Cristian Lindner; Iván Schneider; Ileana Gonzàlez; Hernan Araya; Erik Morales; Milibeth Gómez; Nelson Urdaneta; Paulina Araya; Miguel Angel Morales
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

10.  An Investigation of the Antigastric Cancer Effect in Tumor Microenvironment of Radix Rhei Et Rhizome: A Network Pharmacology Study.

Authors:  Xinmiao Wang; Guanghui Zhu; Haoyu Yang; Ruike Gao; Zhe Wu; Ying Zhang; Xiaoyu Zhu; Xiaoxiao Zhang; Jie Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-24       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.